Doctors were hopeful the drug, which was being tested in a large clinical trial by Novartis, was going to be a powerful new tool to fight heart disease.
The Heart Drug Pelacarsen Fails, Shocking Novartis and Cardiologists
The New York Times – Business:
This post first appeared in The New York Times – Business. Read the original article.
Written by
in